Loading resource…

AHMED M. ABDELHADY; DUSTIN SPENCER; BRIAN R. OVERHOLSER
The document delves into the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs, starting with amiodarone's classification, electrophysiological effects, and indications for treating ventricular arrhythmias and atrial fibrillation. It then transitions to lidocaine, discussing population-based dosing parameters, adjustments for disease states like heart failure and liver dysfunction, and various traditional and alternative dosing regimens. Finally, it presents case studies on calculating maintenance doses for drugs like procainamide, considering patient-specific pharmacokinetic parameters and potential drug interactions that can affect drug levels.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

OXFORD CASE HISTORIES IN CARDIOLOGY
Same clinical topic · Cardiology

PERICARDIOCENTESIS: ULTRASOUND GUIDANCE IS ESSENTIAL
Same clinical topic · Cardiology

The Little Black Book of ECG Secrets
Same clinical topic · Cardiology

CRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENT
Same specialty · Cardiology

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Same specialty · Cardiology

2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Same specialty · Cardiology

2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults
Same specialty · Cardiology

2026 ESC GUIDELINES FOR THE MANAGEMENT OF CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE
Same specialty · Cardiology

2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
Same specialty · Cardiology